Guardant Health (NASDAQ:GH) has received approval from the U.S. FDA for its Guardant360 CDx, which serves as a companion diagnostic tool. The Guardant360 CDx is specifically approved for use alongside Inluriyo, developed by Eli Lilly (LLY), in treating adults ...